CeriBell, Inc. (CBLL)Healthcare | Medical Devices | Sunnyvale, United States | NasdaqGS
26.14 USD
+0.88
(3.484%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 26.14 |
Hot Take ↕ | Oct. 10, 2026, 5:16 a.m. EDT
The investment case for CeriBell is currently broken by a severe disconnect between its promising revenue growth and its deteriorating financial reality. While the company boasts a 32.5% revenue increase and healthy gross margins, it is burning cash aggressively with negative operating cash flow and a massive hole in the bottom line. This fundamental rot is reflected in the stock's brutal 52% drop over the last year, which has erased much of the prior rally. The balance sheet is fragile, with free cash flow draining reserves faster than they can be replenished, and the market has rightly punished this with a crushing valuation compression. There is no dividend to provide a floor, and the options market shows almost no speculative energy, confirming that smart money is staying away. Until the path to profitability becomes clear and cash burn slows, this remains a high-risk speculative vehicle rather than a viable investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.164363 |
| AutoARIMA | 0.164908 |
| AutoETS | 0.164929 |
| AutoTheta | 0.170593 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 7.94 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.044 |
| Excess Kurtosis | -1.51 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 17.075 |
| Revenue per Share | 2.725 |
| Market Cap | 1,003,203,520 |
| Forward P/E | -16.20 |
| Beta | 0.93 |
| Profit Margins | -64.73% |
| Website | https://www.ceribell.com |
As of Oct. 10, 2026, 5:16 a.m. EDT: Speculator positioning is extremely thin across all expirations, indicating a lack of institutional interest or significant directional conviction. Call Open Interest is heavily concentrated at-the-money (around the $25 strike), suggesting traders are hedging current volatility rather than betting on a breakout. Put activity is negligible and scattered, with no meaningful wall of protection at lower strikes. The implied volatility surface shows elevated premiums for longer-dated contracts relative to near-term ones, hinting at a fear of a slow, grinding decline rather than a sharp crash.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0272872 |
| Address1 | 360 North Pastoria Avenue |
| All Time High | 32.749 |
| All Time Low | 10.01 |
| Ask | 32.01 |
| Ask Size | 2 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 331,330 |
| Average Daily Volume3 Month | 378,984 |
| Average Volume | 378,984 |
| Average Volume10Days | 331,330 |
| Beta | 0.931 |
| Bid | 18.77 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 3.357 |
| City | Sunnyvale |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 26.14 |
| Current Ratio | 9.177 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 26.625 |
| Day Low | 24.895 |
| Debt To Equity | 17.075 |
| Display Name | CeriBell |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,393,800 |
| Earnings Call Timestamp Start | 1,786,393,800 |
| Earnings Timestamp | 1,786,392,000 |
| Earnings Timestamp End | 1,793,736,000 |
| Earnings Timestamp Start | 1,793,736,000 |
| Ebitda | -68,803,000 |
| Ebitda Margins | -0.67477995 |
| Enterprise To Ebitda | -13.021 |
| Enterprise To Revenue | 8.786 |
| Enterprise Value | 895,851,584 |
| Eps Current Year | -1.96311 |
| Eps Forward | -1.61315 |
| Eps Trailing Twelve Months | -1.76 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 23.3964 |
| Fifty Day Average Change | 2.743599 |
| Fifty Day Average Change Percent | 0.11726586 |
| Fifty Two Week Change Percent | 102.72872 |
| Fifty Two Week High | 26.625 |
| Fifty Two Week High Change | -0.4850006 |
| Fifty Two Week High Change Percent | -0.018215986 |
| Fifty Two Week Low | 10.85 |
| Fifty Two Week Low Change | 15.289999 |
| Fifty Two Week Low Change Percent | 1.4092164 |
| Fifty Two Week Range | 10.85 - 26.625 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,728,653,400,000 |
| Float Shares | 26,457,863 |
| Forward Eps | -1.61315 |
| Forward P E | -16.20432 |
| Free Cashflow | -33,047,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 327 |
| Fullday Change | 0.87999916 |
| Fullday Change Percent | 3.4837654 |
| Fullday Price | 26.14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.88899004 |
| Gross Profits | 90,645,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11837 |
| Held Percent Institutions | 0.89614 |
| Implied Shares Outstanding | 38,378,101 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California. |
| Market | us_market |
| Market Cap | 1,003,203,520 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_531649318 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -65,997,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 906,490,745 |
| Number Of Analyst Opinions | 7 |
| Open | 25.35 |
| Operating Cashflow | -54,032,000 |
| Operating Margins | -0.71114 |
| Overall Risk | 7 |
| Phone | 800 436 0826 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 26.14 |
| Post Market Time | 1,791,921,678 |
| Previous Close | 25.26 |
| Price Eps Current Year | -13.315606 |
| Price Hint | 2 |
| Price To Book | 7.786714 |
| Price To Sales Trailing12 Months | 9.838801 |
| Profit Margins | -0.64725995 |
| Quick Ratio | 8.445 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.125 |
| Region | US |
| Regular Market Change | 0.879999 |
| Regular Market Change Percent | 3.48377 |
| Regular Market Day High | 26.625 |
| Regular Market Day Low | 24.895 |
| Regular Market Day Range | 24.895 - 26.625 |
| Regular Market Open | 25.35 |
| Regular Market Previous Close | 25.26 |
| Regular Market Price | 26.14 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 542,696 |
| Return On Assets | -0.23382999 |
| Return On Equity | -0.43929002 |
| Revenue Growth | 0.325 |
| Revenue Per Share | 2.725 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 38,378,101 |
| Shares Percent Shares Out | 0.052600004 |
| Shares Short | 2,017,836 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,906,873 |
| Short Name | CeriBell, Inc. |
| Short Percent Of Float | 0.0806 |
| Short Ratio | 5.7 |
| Source Interval | 15 |
| State | CA |
| Symbol | CBLL |
| Target High Price | 33.0 |
| Target Low Price | 24.0 |
| Target Mean Price | 28.57143 |
| Target Median Price | 29.0 |
| Total Cash | 129,261,000 |
| Total Cash Per Share | 3.368 |
| Total Debt | 21,909,000 |
| Total Revenue | 101,964,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.76 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 20.4463 |
| Two Hundred Day Average Change | 5.693699 |
| Two Hundred Day Average Change Percent | 0.27847087 |
| Type Disp | Equity |
| Volume | 542,696 |
| Website | https://www.ceribell.com |
| Zip | 94,085 |